D
MiNK Therapeutics, Inc. INKT
$14.57 -$0.33-2.22% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -19.53% -38.95% -41.95% -22.19% -14.03%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -28.54% -44.08% -43.36% -44.23% -37.82%
Operating Income 28.54% 44.08% 43.36% 44.23% 37.82%
Income Before Tax 34.03% 52.69% 51.98% 44.36% 34.23%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 34.03% 52.69% 51.98% 44.36% 34.23%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 34.03% 52.69% 51.98% 44.36% 34.23%
EBIT 28.54% 44.08% 43.36% 44.23% 37.82%
EBITDA 29.25% 44.79% 44.03% 44.66% 38.20%
EPS Basic 41.90% 58.01% 55.52% 46.74% 36.06%
Normalized Basic EPS 36.22% 51.70% 49.12% 46.88% 36.23%
EPS Diluted 29.14% 47.54% 46.19% 46.93% 36.28%
Normalized Diluted EPS 36.22% 51.70% 49.12% 46.88% 36.23%
Average Basic Shares Outstanding 12.59% 12.88% 9.79% 6.73% 3.61%
Average Diluted Shares Outstanding 12.59% 12.88% 9.79% 6.73% 3.61%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --